In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB

Molecular and Cellular Biology

Volumn 15, Issue 3, 1995, Pages 1294-1301

  Alkalay, Irit ^a   Yaron, Avraham ^a   Hatzubai, Ada ^a   Jung, Steffen ^a   Avraham, Ayelet ^a   Gerlitz, Ofer ^a   Pashut Lavon, Iris ^a   Ben Neriah, Yinon ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0028985191     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.15.3.1294     Document Type: Article

References (61)

1. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217.
2. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
3. Baeuerle, P. A., and D. Baltimore. 1989. A p65 κD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689-1698.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 17:141-179.
5. Bauskin, A. R., I. Alkalay, and V. Ben-Neriah. 1991. Redox regulation of a protein tyrosine kinase in the endoplasmatic reticulum. Cell 66:685-696.
6. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of the Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
7. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
8. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
9. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17: 135-140.
10. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB. Proc. Natl. Acad. Sci. USA 90:2532-2536.
11. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of IκB activity. Proc. Natl. Acad. Sci. USA 91:28-32.
12. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355-361.
13. Davies, N., S. Ghosh, D. L. Simmons, P. Tempst, D.-H. Chiou, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the Rel family transcription factor. Science 253:1268-1271.
14. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15:1302-1311.
15. Figueiredo-Pereira, M. E., N. Banik, and S. Wilk. 1994. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J. Neurochem. 62:1989-1994.
16. Frantz, B., E. C. Norby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, J. S. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861-870.
17. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (London) 344:678-682.
18. Gilmore, T. D., and P. J. Morin. 1993. The IκB proteins: members of a multifunctional family. Trends Genet. 9:427-434.
19. Grilli, M., J. J.-S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62.
20. Halliwell, B., and J. M. Gutteridge. 1986. Iron and free radical reactions: two aspects of antioxidant protection. Trends Biochem. Sci. 11:372-375.
21. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurocko, J. A. Sampson, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
22. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB is necessary for activation of transcription factor NF-κB. Nature (London) 365:182-185.
23. Hiller, R., A. Schaefer, R. Zibirre, H. R. Kaback, and G. Koch. 1984. Factors influencing the accumulation of tetraphenylphosphonium cation in HeLa cells. Mol. Cell. Biol. 4:199-202.
24. Hochstrasser, M., and A. Varshavsky. 1990. In vivo degradation of a transcriptional regulator: the yeast α2 repressor. Cell 61:697-708.
25. Hough, R., G. Pratt, and M. Rechsteiner. 1987. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J. Biol. Chem. 262:8303-8313.
26. Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. κB-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244:457-460.
27. Kidd, S. 1992. Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins. Cell 71:623-635.
28. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
29. Lin, W. C., and S. Desiderio. 1994. Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc. Natl. Acad. Sci. USA 91:2733-2737.
30. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
31. Lion, H. C., and D. Baltimore. 1993. Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
32. Mattila, P. S., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9:4425-4433.
33. Mehdi, S. 1991. Cell-penetrating inhibitors of calpain. Trends Biochem. Sci. 16:150-153.
34. Mellits, K. H., R. T. Hay, and S. Goodbourn. 1993. Proteolytic degradation of MAD3 (IκB) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059-5066.
35. Melloni, E., and S. Pontremoli. 1989. The calpains. Trends Neurochem. Sci. 12:438-444.
36. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB mediated signal transduction. Genes Dev. 7:705-708.
37. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
38. Orlowski, M. 1993. The multicatalytic proteinase complex (proteasome) and intracellular protein degradation: diverse functions of an intracellular particle. J. Lab. Clin. Med. 121:187-189.
39. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32:1563-1572.
40. Orlowski, M., and C. Michaud. 1989. Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry 28:9270-9278.
41. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
42. Peters, J.-M. 1994. Proteasomes: protein degradation machines of the cell. Trends Biochem. Sci. 19:377-382.
43. Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκB. EMBO J. 12:4685-4695.
44. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
45. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
46. Sasaki, T., M. Kishi, M. Saito, T. Tanaka, N. Higuchi, E. Kominami, N. Katunuma, and T. Murachi. 1990. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J. Enzyme Inhib. 3:195-201.
47. Scheinman, R. I., A. A. Beg, and A. S. Baldwin, Jr.. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
48. Schreck, R., B. Meier, D. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181-1194.
49. Schreiber, S. L. 1992. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70:365-368.
50. Scott, M. L., T. Fujita, H. C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7:1266-1276.
51. Sen, R., and D. Baltimore. 1986. Inducibility of immunoglobin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921-928.
52. Shirakawa, F., and S. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424-2430.
53. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736.
54. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκB: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
55. Sun, S. C., P. A. Ganchi, C. Braud, D. W. Ballard, and W. C. Greene. 1994. Autoregulation of the NF-κB transactivator Rel A (p65) by multiple cytoplasmic inhibitors containing anltyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346-1350.
56. Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J. C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol. 12:2898-2908.
57. Umlauf, S. W., B. Beverly, S.-M. Kang, K. Brorson, A.-C. Tran, and R. H. Schwartz. 1993. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunol. Rev. 133:177-197.
58. Vinitsky, A., C. Michaud, J. C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421-9428.
59. Wang, K. W., A. Villalobo, and B. D. Roufogalis. 1989. Calmodulin binding proteins as calpain substrates. Biochem. J. 262:693-706.
60. Zabel, U., and P. A. Baeuerle. 1990. Purified human IκB rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255-265.
61. Zabel, U., T. Henkel, M. dos Santus Silva, and P. A. Baeuerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12:201-211.